We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Mikhail Kosiborod

Mikhail Kosiborod MD

Professor of Medicine, University of Missouri-Kansas City; Cardiologist, Saint-Luke’s Mid America Heart Institute, Kansas City, Missouri

Dr. Kosiborod is a cardiologist at Saint-Luke’s Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City. Dr. Kosiborod received training in clinical research through the Robert Wood Johnson Clinical Scholars Program, as well as clinical training in cardiovascular medicine at Yale University School of Medicine. Dr. Kosiborod is an internationally recognized expert in the field of diabetes management in patients with cardiovascular disease. He has authored numerous peer-reviewed publications on these topics, including scientific statements, and is involved in clinical trials of patients with diabetes and cardiovascular disease – both in the leadership role, as well as the investigator at Saint Luke’s Mid America Heart Institute through the Lipid and Diabetes Research Center. Dr. Kosiborod is actively involved in the work of multiple committees for the American College of Cardiology and American Heart Association, and currently chairs the Diabetes Committee of the American Heart Association.

Recent Contributions to PracticeUpdate:

  1. Diabetes, Pre-Diabetes, and Subclinical Myocardial Damage